Search - tctmd.com

Displaying 261 - 280 of 333

Sort: Relevancy | Date

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Conference News TCT 2015

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

October 12, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Industry News

Miracor Medical Systems Launches PiCSO® Impulse System in Asia

September 21, 2015

News Conference News ESC 2015

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

L.A. McKeown

August 30, 2015

News Conference News ESC 2015

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

Caitlin E. Cox

August 30, 2015

News Industry News

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

August 26, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

Advertisement

Post-TAVR Myocardial Injury Linked to Mortality

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

Novel Devices Present New Treatment Options for STEMI

Miracor Medical Systems Launches PiCSO® Impulse System in Asia

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

ILUMIEN I Published: OCT Can Affect PCI Strategy

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

DES, BMS Both Suitable for Treating Patients With SVG Lesions

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content